• Travere Therapeutics (NASDAQ:TVTX) Earns "Overweight" Rating from Cantor Fitzgerald

    ソース: Buzz FX / 22 2 2025 13:56:17   America/New_York


    Travere Therapeutics (NASDAQ:TVTX) Earns "Overweight" Rating from Cantor Fitzgerald Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Travere Therapeutics ( NASDAQ:TVTX - Get Free Report ) 's stock had its "overweight"
    Read more...
シェアする